Afanix 40 mg (Afatinib)

Afanix 40 mg (Afatinib)

Afanix 40mg medicine contains the main ingredient Afatinib is a targeted therapy drug used to treat lung cell carcinoma (NSCLC) researched and manufactured by Beacon pharmaceutical company – Bangladesh.

Category: Tags: ,
Contact Us

What is Afanix 40mg (Afatinib)?

  • Afanix is ​​a targeted therapy (Afatinib) classified as a Tyrosine Kinase inhibitor, an inhibitor of epidermal growth factor (EGFR).
  • Afanix medicine contains the ingredient Afatinib 40mg, which is a Protein Kinase inhibitor that also irreversibly inhibits (HER2) and (EGFR) to help stop cancer cells and prolong life for patients.
  • Afanix medicine 40mg (Afatinib) is manufactured by Beacon pharmaceutical company – Bangladesh, which is a large pharmaceutical company in the world providing effective cancer treatment brand-name drugs.

Drug Information Afanix 40

  • Brand Name: Afanix
  • Active ingredient: Afatinib
  • Drug group: Medicines for the treatment of lung cancer
  • Content: 40 mg
  • Form: Tablets
  • Packaging: 1 box of 30 tablets
  • Producer: Beacon

Uses & Indications of Afanix 40mg (Afatinib)

Indications for Afanix 40

Afanix 40 is indicated for:

  • Treatment of EGFR-positive, metastatic non-small cell lung cancer that has spread to nearby tissues or to other parts of the body.
  • Treatment of patients with advanced squamous metastatic NSCLC after chemotherapy (metastatic Squamous NSLC)

Drug Contraindications

  • The patient is allergic to any of the ingredients in the drug.
  • Pregnant and lactating women are not recommended to take Afanix.
  • Afanix is ​​not recommended for use in children under 18 years of age.

Related products